.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
10.26.2023
Key Considerations When Partnering with a CDMO for Your Plasma-Derived Therapies
Plasma contains an array of beneficial constituents that, when purified and concentrated, can be administered as medicines to...
News & Insights
Emergent Bioservices News, Insights & Events
Stay informed with news, expert thought leadership, featured articles and engaging content from Emergent Bioservices and see what events we’ll be attending throughout the year.
07.20.2023
Outsourced Pharma Capacity Update | July 2023
Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its...
06.29.2023
Case Study Corner: Streamlining R&D to Manufacturing
Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible...
06.28.2023
4 Steps for a Smooth Tech Transfer When Working with a CDMO
In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing...
05.31.2023
Facility Spotlight: Drug Product Manufacturing in Maryland
Located just 10 minutes from Emergent headquarters, our 70,000 sq. ft. Rockville, MD (USA) facility provides drug product...
04.26.2023
Case Study Corner: LNP Formulation
Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible...